21-hydroxylase deficiency natural history, complications and prognosis: Difference between revisions
| Line 19: | Line 19: | ||
*The prognosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency is generally good with treatment. | *The prognosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency is generally good with treatment. | ||
* A small percentage of children and adults with infancy or childhood onset congenital adrenal hyperplasia die of adrenal crisis, even after diagnosis and initiation of treatment. | * A small percentage of children and adults with infancy or childhood onset congenital adrenal hyperplasia die of adrenal crisis, even after diagnosis and initiation of treatment. | ||
* Deaths from this are entirely avoidable if the child and his family understand that the daily [[glucocorticoids]] must not | * Deaths from this are entirely avoidable if the child and his family understand that the daily [[glucocorticoids]] doses must not be interrupted by an illness. | ||
* When a person is well, missing a dose, or even several doses, may produce little in the way of immediate symptoms. However, glucocorticoid needs are increased during illness and stress. | * When a person is well, missing a dose, or even several doses, may produce little in the way of immediate symptoms. However, glucocorticoid needs are increased during illness and stress. | ||
* Missed doses during time of illness can lead (within hours) to [[hypotension]], [[Shock (medical)|shock]], and death. | * Missed doses during time of illness can lead (within hours) to [[hypotension]], [[Shock (medical)|shock]], and death. | ||
Revision as of 14:44, 5 October 2015
|
Congenital adrenal hyperplasia due to 21-hydroxylase deficiency Microchapters |
|
Differentiating Congenital adrenal hyperplasia due to 21-hydroxylase deficiency from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
21-hydroxylase deficiency natural history, complications and prognosis On the Web |
|
American Roentgen Ray Society Images of 21-hydroxylase deficiency natural history, complications and prognosis |
|
FDA on 21-hydroxylase deficiency natural history, complications and prognosis |
|
CDC on 21-hydroxylase deficiency natural history, complications and prognosis |
|
21-hydroxylase deficiency natural history, complications and prognosis in the news |
|
Blogs on 21-hydroxylase deficiency natural history, complications and prognosis |
|
Directions to Hospitals Treating Congenital adrenal hyperplasia due to 21-hydroxylase deficiency |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Ahmad Al Maradni, M.D. [2]
Overview
Common complications of 21-hydroxylase deficient congenital adrenal hyperplasia include short stature, adrenal crisis, infertility, and precocious puberty. The prognosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency is generally good with treatment.
Complications
Common complications associated with 21-hydroxylase deficient congenital adrenal hyperplasia include:
Prognosis
- The prognosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency is generally good with treatment.
- A small percentage of children and adults with infancy or childhood onset congenital adrenal hyperplasia die of adrenal crisis, even after diagnosis and initiation of treatment.
- Deaths from this are entirely avoidable if the child and his family understand that the daily glucocorticoids doses must not be interrupted by an illness.
- When a person is well, missing a dose, or even several doses, may produce little in the way of immediate symptoms. However, glucocorticoid needs are increased during illness and stress.
- Missed doses during time of illness can lead (within hours) to hypotension, shock, and death.